HRES 510 is a symbolic resolution recognizing the 20th anniversary of the Children’s Hospital Association’s Family Advocacy Day. It honors the contributions of children’s hospitals, patients, and families who share their health care stories with lawmakers, and commends the Children’s Hospital Association for its 20 years of advocacy. The resolution does not create new laws or funding but expresses the House’s support for pediatric health care and its call to protect access to care, address youth mental health, and strengthen the pediatric workforce. This is a ceremonial acknowledgment with no binding policy impact.
This bill requires Medicare to establish national payment rates for qualifying pediatric medical devices when manufacturers request it. It directly affects device manufacturers and Medicare by creating a formal process to set these rates, which are used to reimburse doctors for using these devices. Key provisions include a timeline for requests (by May 1 annually), requiring manufacturers to submit data like pricing and claims information, and defining qualifying devices as those approved for pediatric use in procedures predominantly for children or specifically designed for them. The bill does not change Medicare coverage requirements but streamlines payment rate establishment for existing approved devices.
Health Care Freedom for Patients Act of 2025 This bill allows certain individuals with health savings accounts (HSAs) to receive federal payments. It also restricts payments under Medicaid and the Children's Health Insurance Program (CHIP) regarding certain noncitizens and restricts coverage of gender-transition procedures. Specifically, the bill provides funds for the Department of Health and Human Services to deposit payments into an individual’s HSA during 2026-2027 if the individual has a bronze or catastrophic plan through a health insurance exchange, is between the ages of 18 and 64, and has income up to 700% of the federal poverty level (FPL). Individuals may receive $1,000 or $1,500 annually, depending on age. The bill also provides funds, beginning in 2027, for cost-sharing reductions for certain individuals who have a silver plan and income up to 250% of the FPL. Beginning in 2027, the bill allows any individual to enroll in a catastrophic plan. Currently, these plans are limited to those under the age of 30 or who have certain exemptions. The bill also reduces the enhanced federal matching rate for the Medicaid expansion population in states that provide any health benefits for individuals who are not qualified aliens under federal law. The bill makes Medicaid and CHIP coverage of individuals while their status is being verified optional and conditions federal payment during this period on verification. Finally, the bill prohibits exchange plans from covering gender-transition procedures as an essential health benefit and prohibits federal payment under Medicaid and CHIP for these procedures.
This bill would deny federal tax deductions for gender transition procedures and prohibit Medicaid, Medicare, and Children's Health Insurance Program (CHIP) funding for such procedures. It defines gender transition procedures broadly to include hormonal treatments, surgeries, and cosmetic procedures intended to align physical appearance with gender identity, with limited exceptions for medically necessary treatments related to disorders of sex development or life-threatening conditions. The legislation would also require health insurance plans to exclude gender transition procedures from essential health benefits under the Affordable Care Act. This would directly affect individuals seeking gender transition care who rely on federal health programs or tax deductions for medical expenses.
This non-binding Senate resolution (SRES 389) condemns Secretary of Health and Human Services Robert F. Kennedy, Jr.'s actions dismissing the CDC's independent Advisory Committee on Immunization Practices and opposes Florida's 2025 policy rolling back school immunization requirements for children. It affirms that vaccines are critical for public health, preventable illness, and hospitalization reduction, and must be widely accessible at high community adoption rates. The resolution expresses the Senate's support for science-based vaccine policies, opposes politicizing medical recommendations, and emphasizes that vaccines should remain affordable and available through insurance and community settings like clinics and pharmacies. It does not create new laws but formally states the Senate's position against policies it views as endangering public health.
House Resolution 388 designates the first week of April as "Adolescent Immunization Action Week" to promote vaccination for teens and young adults. The resolution calls on communities, health providers, and organizations to support immunization efforts, particularly addressing vaccine misinformation and low uptake in rural and underserved areas. It does not create new laws or funding but encourages collaborative action to improve vaccination rates for adolescents.
This bill requires the Health and Human Services Secretary to create a process by January 1, 2026, allowing specific healthcare research groups (qualified clinical data registries and clinician-led registries) to access Medicare claims data, and potentially Medicaid/CHIP data if approved. These groups can link claims data with clinical outcomes to assess provider quality, improve patient safety, and conduct research. The data will be provided at cost (covering only the fee to make it available), with fees deposited into the CMS account. It directly affects healthcare researchers and providers by enabling data-driven quality improvement efforts.
HR 1433, the Kids’ Access to Primary Care Act of 2025, sets a minimum Medicaid payment rate of 100% of Medicare’s rate for primary care services provided to children. It directly affects Medicaid-covered children and expands eligibility for providers to include pediatricians, family medicine physicians, nurse practitioners, physician assistants, certified nurse-midwives, and rural health clinics or Federally-qualified health centers (FQHCs) under specific conditions. Key provisions require Medicaid managed care plans to pay these providers at the minimum rate, with documentation requirements to verify compliance, and exclude emergency department services from the definition of primary care. The bill also mandates a study to track enrollment and payment rate changes across states after implementation.
This bill would require states to create a simplified process for out-of-state healthcare providers to join Medicaid and CHIP programs. Qualified providers (those already enrolled in Medicare or another state's program with low fraud risk) could enroll without excessive screening and would be approved for five years. It directly affects children under 21 enrolled in Medicaid or CHIP by expanding access to providers outside their state, particularly in underserved areas. The change applies to all states' Medicaid programs but takes effect three years after enactment.
HRES 419 designates May 17, 2025, as "DIPG Awareness Day" to raise public awareness about diffuse intrinsic pontine glioma (DIPG), a fatal pediatric brain cancer with a median survival of 9 months and less than 1% 5-year survival rate. The resolution encourages public and private funding sources to prioritize research for DIPG and other pediatric cancers by considering mortality rates and life-years lost when allocating grants. It does not create new laws but symbolically urges greater attention to this unmet medical need.
